Lighthouse Investment Partners’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.24M Buy
+67,554
New +$2.9M 0.09% 286
2026
Q1
– Sell
-35,000
Closed -$1.78M – 957
2025
Q4
$1.78M Buy
+35,000
New +$1.79M 0.05% 374
2025
Q1
– Sell
-38,500
Closed -$3.31M – 592
2024
Q4
$3.31M Buy
+38,500
New +$4.16M 0.11% 221
2024
Q3
– Sell
-25,619
Closed -$3.42M – 519
2024
Q2
$3.66M Buy
+25,619
New +$3.39M 0.15% 168

Other funds holding NVO

Lighthouse Investment Partners's NVO Position: Q2 2026 in Review

Lighthouse Investment Partners opened a new position in Novo Nordisk (NVO) in Q2 2026: 67,554 shares worth $3.24M. The stake represents 0.09% of the portfolio and ranks #286 among its holdings. This is a return to the name: Lighthouse Investment Partners previously reported a position in NVO as recently as Q4 2025.

Lighthouse Investment Partners first reported a position in NVO in Q2 2024 and has held it in 4 quarters since. The position peaked at $3.66M in Q2 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Lighthouse Investment Partners held 67,554 shares of Novo Nordisk worth $3.24M as of Q2 2026.
  • Novo Nordisk was a new Lighthouse Investment Partners position in Q2 2026.
  • Novo Nordisk made up 0.09% of Lighthouse Investment Partners's portfolio in Q2 2026, its #286 holding.
  • Lighthouse Investment Partners first reported a position in Novo Nordisk in Q2 2024 and has held it in 4 quarters since.
  • Lighthouse Investment Partners's Novo Nordisk position peaked at $3.66M in Q2 2024.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Lighthouse Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.